Face Mask Therapy and Rapid Maxillary Expansion on Blood Oxygen Levels in Class III Malocclusion
Class III Malocclusion
Malocclusion+1
+ Malocclusion, Angle Class III
+ Stomatognathic Diseases
Diagnostic Study
Summary
Study start date: January 1, 2024
Actual date on which the first participant was enrolled.This study focuses on the effects of using a face mask therapy combined with rapid maxillary expansion (RME) in children with a specific dental issue called Class III malocclusion. This condition occurs when the upper jaw is too far back or the lower jaw is too far forward, or both. The therapy aims to encourage the forward growth of the upper jaw, helping to realign the teeth and improve the bite. The study is important because it examines how this treatment might also impact blood oxygen levels and breathing, especially since mouth breathing is common in people with this condition and can affect overall respiratory health. Participants in the study will undergo treatment involving the use of a face mask appliance, which applies gentle pressure to move the upper jaw forward. This treatment is often paired with RME to enhance the outcome. The study will monitor changes in the dental alignment and airway spaces, as well as measure blood oxygen levels using a device called a pulse oximeter. This device uses light to determine how much oxygen is in the blood, providing insights into how the treatment affects breathing. The potential benefits of the study could include improved dental alignment, better breathing, and a better understanding of how these factors are connected.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.24 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 6 to 10 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: 6-10 years of age Class III Malocclusion \- Exclusion Criteria: * +10 years of age
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalGroup III
Active ComparatorStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location